Detalhe da pesquisa
1.
RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study.
Mol Cancer
; 23(1): 64, 2024 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38532456
2.
Metastatic extraneural glioblastoma diagnosed with molecular testing.
Oncologist
; 2024 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38837109
3.
Financial distress and its associated burden in couples coping with an advanced cancer.
Support Care Cancer
; 30(5): 4485-4495, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35112209
4.
Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201.
J Neurooncol
; 145(1): 97-105, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31456142
5.
A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma.
J Neurooncol
; 129(3): 487-494, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27406589
6.
Current challenges in designing GBM trials for immunotherapy.
J Neurooncol
; 123(3): 331-7, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25577401
7.
VEGF Manipulation in Glioblastoma.
Oncology (Williston Park)
; 29(10): 720-7, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26470893
8.
Resistance to antiangiogenic therapy.
Curr Neurol Neurosci Rep
; 14(5): 443, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24652451
9.
Perspectives from neuro-oncology providers on patient access to electronic records: a survey study.
CNS Oncol
; 13(1): 2352414, 2024 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38869443
10.
Associations Between Stress, Health Behaviors, and Quality of Life in Young Couples During the Transition to Survivorship: Protocol for a Measurement Burst Study.
JMIR Res Protoc
; 13: e53307, 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38652520
11.
Histological transformation to gliosarcoma with combined BRAF/MEK inhibition in BRAF V600E mutated glioblastoma.
NPJ Precis Oncol
; 7(1): 47, 2023 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37231247
12.
Dyadic versus individual delivery of a yoga program for family caregivers of glioma patients undergoing radiotherapy: Results of a 3-arm randomized controlled trial.
Cancer Med
; 12(6): 7567-7579, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36468605
13.
Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience.
Neurooncol Adv
; 5(1): vdad032, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37114244
14.
Assessing mobility in primary brain tumor patients: A descriptive feasibility study using two established mobility tests.
Neurooncol Pract
; 9(3): 219-228, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35601968
15.
A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma.
CNS Oncol
; 11(2): CNS87, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35575067
16.
Results of a phase I trial to assess the safety of macitentan in combination with temozolomide for the treatment of recurrent glioblastoma.
Neurooncol Adv
; 3(1): vdab141, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34693288
17.
Aggressiveness of care at end of life in patients with high-grade glioma.
Cancer Med
; 10(23): 8387-8394, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34755486
18.
Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experience.
Neurooncol Adv
; 3(1): vdab079, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34377987
19.
Dual inhibition of BRAF and mTOR in BRAFV600E -mutant pediatric, adolescent, and young adult brain tumors.
Cold Spring Harb Mol Case Stud
; 6(4)2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32843426
20.
Management of a patient with mantle cell lymphoma who developed severe neurotoxicity after chimeric antigen receptor T-cell therapy in ZUMA-2.
J Immunother Cancer
; 8(2)2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33067318